Neurology® Podcast
American Academy of Neurology
The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
Episodes
Mentioned books
Nov 22, 2021 • 20min
International Headache Congress 2021; Speech Subtypes in Parkinson Disease
In the first part of the podcast, Dr. Tesha Monteith discusses the International Headache Society and European Headache Federation 2021 joint International Headache Congress with Dr. Patricia Pozo-Rosich (00:45). In the second segment, Dr. Jeff Ratliff talks with Dr. Jan Rusz about identifying speech subtypes in patients with Parkinson disease in response to long-term dopaminergic therapy (8:18).
Nov 15, 2021 • 27min
Dopamine Therapy in Early PD; Neurologic Disease Definitions with Immune Checkpoint Inhibitors
In the first part of the podcast, Dr. Jason Crowell discusses the AAN Guideline Subcommittee's practice guideline summary on dopaminergic therapy for motor symptoms in early Parkinson disease with Dr. Anthony Lang (00:45). In the second segment, Dr. Kathryn Nevel talks with Dr. Amanda Guidon about the development of consensus disease definitions for neurologic immune-related adverse events associated with immune checkpoint inhibitors (17:04).
Nov 8, 2021 • 41min
Chronic Meningitis; MS Therapies and COVID-19
In the first part of the podcast, Dr. Stacey Clardy discusses the causes, features, evaluation, and treatment of chronic meningeal inflammation or infection with Dr. Allen Aksamit. In the second segment, Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about the associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis (26:48).
Nov 1, 2021 • 26min
Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis
In the first part of the podcast, Dr. Gregg Day discusses the importance of patient participation in the decision-making process when considering the use of aducanumab for the treatment of Alzheimer disease with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer’s Disease Center. In the second segment, Dr. Andy Southerland talks with Dr. Jyri Virta about the risk of aneurysm rupture after thrombolysis in patients with acute ischemic stroke and unruptured intracranial aneurysms.
Nov 1, 2021 • 56min
Lewy Body Dementia (November 2021 Neurology Recall)
Oct 25, 2021 • 21min
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.
Oct 18, 2021 • 30min
Neurologic Safety of COVID-19 Vaccines; Movement Disorders in Anti-IgLON5 Disease
In the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.
Oct 11, 2021 • 22min
CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome
In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.
Oct 4, 2021 • 36min
Peter Frampton on His Diagnosis of Myositis; Ethical Perspectives on Costly Drugs and Healthcare
In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN’s patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.
Oct 1, 2021 • 36min
Thunderclap Headache (October 2021 Neurology Recall)
The October 2021 replay of past episodes showcases a selection of interviews focused on thunderclap headache. This episode features Dr. Tesha Monteith in conversation with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, as well as with headache experts Drs. Jonathan Smith, Dileep Yavagal, and Alexandra Cocores.
